KALARIS THERAPEUTICS, INC. (KLRS) Operating cash flow 2019–2025
KALARIS THERAPEUTICS, INC. (KLRS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$38.4MFY2025 · since FY2019: -$20.2M → -$38.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.4M | -85.6% |
| FY2024 | -$20.7M | +83.4% |
| FY2023 | -$124.5M | +12.4% |
| FY2022 | -$142.1M | -33.6% |
| FY2021 | -$106.3M | -74.8% |
| FY2020 | -$60.8M | -201.7% |
| FY2019 | -$20.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice